Colorado Springs Urological Associates (CSUA) Signed Definitive Agreement With Solaris Health to Join the Nation’s Largest Urological Services Provider

CSUA Seizes Innovation Opportunities Presented by Dynamic National Urology Platform Caring for More than One-Half Million Patients

Solaris Health Holdings announced today that Colorado Springs Urological Associates (CSUA), serving Colorado Springs, CO, and the surrounding area, has entered into a definitive agreement to join as an affiliate practice. Terms have not been disclosed.

The agreement with CSUA extends the reach of the national Solaris platform to the Mountain West. Solaris is the nation’s leading provider of independent urological services. CSUA will become the fifth urology practice this year to join Solaris.

CSUA is a union of two patient-centric, top-rated urological practices, tracing its roots back 50 years. Upon closing, the addition of CSUA means that Solaris now aligns the skills and talents of 345 providers who care for over 530,000 unique patients each year at more than 135 sites in New York, Ohio, Pennsylvania, Kentucky, Indiana, Illinois, Michigan, and Colorado. The deal is expected to close in Q4 of 2021.

“We welcome CSUA as a practice that shares our vision to develop a national practice predicated on clinical excellence and business best practices,” stated Solaris Chairman and Chief Ecosystem Officer Deepak A. Kapoor, MD. Solaris President, Gary M. Kirsh, MD added, “By choosing to scale nationally, CSUA physicians will maintain their high standards of patient care and gain access to the resources needed to successfully navigate an increasingly complex and consolidated health care system.”

CSUA Market President Jeffrey Moody, MD announced, “The doctors and staff of Colorado Springs Urological Associates are excited about our new partnership with Solaris Health. This brings an entirely new dimension of care, access, service, and technology to southern Colorado urology. We are thrilled to continue to advance the care we provide our community.”

Jeffrey Ferguson, MD, CSUA Director of Business Development and Strategy, added, “This partnership will give our team access to a national urology platform with expertise in clinical care and practice management and help us improve the service we provide to our patients and our community.” Dr. Ferguson will serve on the Solaris Board of Directors.

“The addition of Colorado Springs Urological Associates demonstrates that the appeal of our platform is not constrained by geography and represents a significant boost to the momentum we are building for even greater expansion,” said Eric Mason, MD, MBA, Solaris Health CEO.

McDermott Will & Emery LLP served as legal counsel to Solaris. Physician Growth Partners acted as exclusive financial advisor to CSUA and Lathrop GPM LLP served as legal counsel to CSUA.

New York-based Lee Equity Partners is a financial partner in Solaris.

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy